Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3140-3148

  Leschek, Ellen Werber ^a   Rose, Susan R ^b   Yanovski, Jack A ^a   Troendle, James F ^a   Quigley, Charmian A ^c   Chipman, John J ^c   Crowe, Brenda J ^c   Ross, Judith L ^d,e   Cassorla, Fernando G ^f   Blum, Werner F ^c   Cutler Jr , Gordon B ^c   Baron, Jeffrey ^a,g  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^f UNIVERSITY OF CHILE   (Chile)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EPIPHYSIOLYSIS; FEMALE; GYNECOMASTIA; HODGKIN DISEASE; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCOLIOSIS; SHORT STATURE; SIDE EFFECT;

ADOLESCENT; BODY HEIGHT; CHILD; DOUBLE-BLIND METHOD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MALE; PLACEBOS; PUBERTY; TREATMENT OUTCOME;

EID: 3242699910     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031457     Document Type: Article

References (51)

1. Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B, Massa GG 1995 Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol (Oxf) 42:365-372
2. Root AW, Kemp SF, Rundle AC, Dana K, Attie KM 1998 Effect of long-term recombinant growth hormone therapy in children - the National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 11:403-412
3. Cuttler L, Silvers JB, Singh J, Marrero U, Finkelstein B, Tannin G, Neuhauser D 1996 Short stature and growth hormone therapy. A national study of physician recommendation patterns. JAMA 276:531-537
4. Maneatis T, Baptista J, Connelly K, Blethen S 2000 Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 13:1035-1044
5. Wilton P 1999 Adverse events during GH treatment: 10 years' experience in KIGS, a pharmacoepidemiological survey. In: Ranke MB, Wilton P, eds. Growth hormone therapy in KIGS - 10 years' experience. Heidelberg: Johann Ambrosius Barth Verlag; 349-364
6. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD, Kaplan SL, Lippe BM, Plotnick LP, Saenger P 1993 Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 123:215-222
7. Barton JS, Gargineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA 1995 The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol (Oxf) 42:619-626
8. Lanes R 1995 Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children. J Pediatr Endocrinol Metab 8:167-171
9. Hintz RL, Attie KM, Baptista J, Roche A 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 340:502-507
10. Kawai M, Momoi T, Yorifuji T, Yhamanaka C, Sasaki H, Furusho K 1997 Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency. J Pediatr 130:205-209
11. Bernasconi S, Street ME, Volta C, Mazzardo G 1997 Final height in non-growth hormone deficient children treated with growth hormone. Clin Endocrinol (Oxf) 4:261-266
12. Wit JM, Kamp GA, Rikken B 1996 Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 39:295-302
13. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M 1994 Final height after growth hormone therapy in non-growth-hormone-deficient short stature. J Pediatr 125:196-200
14. Zadik A, Amnon Z 1997 Final height after growth hormone therapy in short children: correlation with siblings' height. Horm Res 48:274-277
15. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH 1998 Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab 83:1075-1079
16. López-Siguero JP, García-Garcia E, Carralero I, Martínez-Aedo MJ 2000 Adult height in children with idiopathic short stature treated with growth hormone. J Pediatr Endocrinol Metab 13:1595-1602
17. Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal J-M 2001 Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab 86:4649-4654
18. Hindmarsh PC, Brook CGD 1996 Final height of short normal children treated with growth hormone. Lancet 348:13-16
19. McCaughey ES, Mulligan J, Voss LD, Betts PR 1998 Randomised trial of growth hormone in short normal girls. Lancet 351:940-944
20. Taback SP, Dean HJ 2002 Evidence-based case reviews: management of short stature. West J Med 176:169-172
21. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe D, Cuttler L 2002 Effect of Growth hormone therapy on height in children with idiopathic short stature. Arch Pediatr Adolesc Med 156:230-240
22. Underwood LE 1984 Report of the conference on uses and possible abuses of biosynthetic human growth hormone. N Engl J Med 311:606-608
23. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler Jr GB 1994 The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79:537-541
24. Bayley N, Pinneau SR 1952 Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40:423-441
25. Tanner JM 1986 Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411-451
26. Zachmann M, Prader A, Kind HP, Hafliger H, Budliger H 1974 Testicular volume during adolescence: cross-sectional and longitudinal studies. Helv Paediatr Acta 129:61-72
27. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
28. Hintz RL, Liu F, Chang D, Seegan GA 1988 Sensitive radioimmunoassay for somatomedin C/insulin-like growth factor-1 based on synthetic insulin-like growth factor 57-70. Horm Metab Res 20:344-347
29. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL 2002 Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60
30. Leschek EW, Troendle JF, Yanovski JA, Rose SR, Bernstein DB, Cutler GB, Baron J 2001 Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: a randomized, double-blind, placebo-controlled trial. J Pediatr 138:406-410
31. Rose SR, Baron J, Bernstein D, Yanovski J, Troendle JF, Leschek E, Chipman J, Cutler GB 2000 Suppression and recovery of GH secretion after GH injection in non-GH deficient short children. J Pediatr Endocrinol Metab 13:281-288
32. Sacks H, Chalmers TC, Smith H 1982 Randomized versus historical controls for clinical trials. Am J Med 72:233-240
33. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A 1978 Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr 93:749-755
34. Bramswig JH, Fasse M, Holthoff ML, Vonlengerke HJ, Vonpetrykowski W, Schellong G 1990 Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction. J Pediatr 117:886-891
35. Boulton TJC, Smith R, Single T 1992 Psychosocial growth failure: a positive response to growth hormone and placebo. Acta Pediatr 81:322-325
36. Rosenbloom AL, Knuth C, Shulman D 1990 Growth hormone by daily injection in patients previously treated for growth hormone deficiency. South Med J 83:653-655
37. MacGillivray MH, Baptista J, Johanson A 1996 Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naïve growth hormone-deficient children. J Clin Endocrinol Metab 81:1806-1809
38. Rekers-Mombarg LTM, Massa GG, Wit JM, Matranga AMC, Buckler JMH, Butenandt O, Chaussain JL, Frisch H, Leiberman E, Yturriaga R, Aarskog D, Chatelain PG, Colle M, Dacou-Voutetakis C, Delemarre-van de Waal HA, Girard F, Gosen JJ, Irle U, Jansen M, Jean R, Job JC, Kaar ML, Kollemann F, Lenko HL, Mublenberg R, Keizer-Schrama SMPFDM, Oostdijk W, Otten BJ, Piersson M, Preece MA, Price DA, Rayner PHW, Rouwe C, Schmitt K, Sippell WG, Blumel P, Vulsma T, Waelkens JJJ 1998 Growth hormone therapy with three dosage regimens in children with idiopathic short stature. J Pediatr 132:455-460
39. Wit JM, Rekers-Mombarg LTM 2002 Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab 87:604-611
40. de Muinck Keizer-Schrama SM, Sas TC 1999 Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone. Acta Paediatr Suppl 88:126-129
41. De Zegher F, Ong K, van Helvoirt M, Mohn A, Woods K, Dunger D 2002 High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab 87:148-151
42. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J 2000 High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. J Clin Endocrinol Metab 85:3653-3660
43. Jorgensen JO, Flyvbjerg A, Lauritzen T, Alberti KG, Orskov H, Christiansen JS 1988 Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab 67:36-40
44. Tanaka T, Seino Y, Fujieda K, Igarashi Y, Yokoya S, Tachibana K, Ogawa Y 1999 Pharmacokinetics and metabolic effects of high-dose growth hormone administration in healthy adult men. Endocr J 46:605-612
45. Walker J, Chaussain JL, Bougneres PF 1989 Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal. J Clin Endocrinol Metab 69:253-258
46. Rekers-Mombarg LT, Kamp GA, Massa GG, Wit JM 1999 Influence of growth hormone treatment on pubertal timing and pubertal growth in children with idiopathic short stature. Dutch Growth Hormone Working Group. J Pediatr Endocrinol Metab 12:611-622
47. Wit JM 1999 Growth hormone treatment of idiopathic short stature in KIGS. In: Ranke MB, Wilton P, eds. Growth hormone therapy in KIGS - 10 years' experience. Heidelberg: Johann Ambrosius Barth Verlag; 225-243
48. Downie AB, Mulligan J, Stratford RJ, Betts PR, Voss LD 1997 Are short normal children at a disadvantage? The Wessex growth study. BMJ 314:97-100
49. Voss LD 2001 Short normal stature and psychosocial disadvantage: a critical review of the evidence. J Pediatr Endocrinol Metab 14:701-711
50. Stabler B, Siegel PT, Clopper RR, Stoppani CE, Compton PG, Underwood LE 1998 Behavior change after growth hormone treatment of children with short stature. J Pediatr 133:366-373
51. National Institute for Clinical Excellence 2002 Technology appraisal guidance no. 42. Full guidance on the use of human growth hormone (somatropin) in children with growth failure. May 22, 2002. London: National Institute for Clinical Excellence; pp 1-24, www.nice.org.uk